- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.08. | UK government's 'science superpower' ambitions to fail without clear plan, Lords committee warns | ||
| 05.08. | Amgen acquires ChemoCentryx in $3.7bn cash deal | ||
| 05.08. | Gilead Sciences set to acquire MiroBio in deal worth over $400m | ||
| 05.08. | NHS England to roll out continuous glucose monitors to all those with type 1 diabetes | ||
| 05.08. | Sanofi and Innovent Biologics to develop oncology drugs for patients in China | ||
| 05.08. | WHO launches funding appeal for greater Horn of Africa prompted by food crisis | ||
| 04.08. | The patient voice - the value of patient-reported outcomes in HTA | ||
| 04.08. | AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval | ||
| 04.08. | Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease | ||
| 04.08. | Eli Lilly to make bebtelovimab commercially available to US states from August | ||
| 04.08. | AbbVie's Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits | ||
| 04.08. | FDA approves Coherus' Cimerli as biosimilar interchangeable with Lucentis for all five indications | ||
| 03.08. | Innovation through collaboration - the importance of partnerships | ||
| 03.08. | WHO, UNICEF and UNAIDS launch global alliance to end AIDS in children by 2030 | ||
| 03.08. | Janssen's Stelara approved by FDA for psoriatic arthritis in paediatric patients | ||
| 03.08. | Alzheimer's Research UK calls for government action to address inequalities in dementia risk | ||
| 03.08. | Arcutis receives FDA approval for steroid-free plaque psoriasis treatment | ||
| 03.08. | Boehringer Ingelheim and QUANTRO Therapeutics partner to develop drug candidates | ||
| 02.08. | 'Who moved my cheese?' | ||
| 02.08. | Achieving communication excellence by targeting the right channel at the right time | ||
| 02.08. | Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV | ||
| 02.08. | Roche's Tecentriq demonstrates positive phase 3 results as a subcutaneous injection | ||
| 02.08. | AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab | ||
| 01.08. | Gilead announces positive Biktarvy data for HIV and hepatitis B | ||
| 01.08. | GSK's ViiV and Medicines Patent Pool agree deal for HIV prevention |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
